| Balance Sheets | 2025-08-31 | |||
|---|---|---|---|---|
| Cash and cash equivalents | 9,332 | |||
| Prepaid expenses | 560 | |||
| Prepaid service fees | 3,458 | |||
| Total current assets | 13,350 | |||
| Other non-current assets | 133 | |||
| Total assets | 13,483 | |||
| Accounts payable | 14,175 | |||
| Accrued interest on convertible notes | 16,577 | |||
| Convertible notes payable, net | 27,200 | |||
| Accrued liabilities and compensation | 2,823 | |||
| Accrued dividends on convertible preferred stock-Series CPreferred Stock | 3,929 | |||
| Accrued dividends on convertible preferred stock-Series DPreferred Stock | 4,713 | |||
| Total current liabilities | 69,417 | |||
| Other liabilities (note 9) | 43,571 | |||
| Total liabilities | 112,988 | |||
| Preferred stock-Series BPreferred Stock | 0 | |||
| Preferred stock-Series CPreferred Stock | 0 | |||
| Preferred stock-Series DPreferred Stock | 0 | |||
| Common stock, 0.001 par value 1,750,000 shares authorized 1,257,045 and 1,249,460 issued, and 1,256,759 and 1,249,174 outstanding at august 31, 2025 and may 31, 2025, respectively | 1,257 | |||
| Additional paid-in capital | 792,564 | |||
| Accumulated deficit | -893,326 | |||
| Total stockholders' deficit | -99,505 | |||
| Total liabilities and stockholders' deficit | 13,483 | |||
CytoDyn Inc. (CYDY)
CytoDyn Inc. (CYDY)